UnitedHealth Group Inc (NYSE:UNH) – Equities research analysts at Piper Jaffray Companies reduced their Q2 2019 earnings per share estimates for UnitedHealth Group in a research report issued on Tuesday, April 16th. Piper Jaffray Companies analyst S. James now expects that the healthcare conglomerate will post earnings per share of $3.40 for the quarter, down from their prior estimate of $3.46. Piper Jaffray Companies also issued estimates for UnitedHealth Group’s Q3 2019 earnings at $3.71 EPS, Q4 2019 earnings at $3.94 EPS, FY2019 earnings at $14.77 EPS and FY2020 earnings at $16.71 EPS.

Several other brokerages also recently commented on UNH. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Oppenheimer increased their price objective on UnitedHealth Group from $300.00 to $305.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 16th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Cantor Fitzgerald reissued a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, January 15th. Finally, Stephens assumed coverage on UnitedHealth Group in a research note on Monday, January 14th. They issued an “overweight” rating and a $287.00 price objective for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating, twenty have issued a buy rating and one has given a strong buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $289.45.

Shares of NYSE:UNH opened at $216.84 on Thursday. The company has a market capitalization of $220.89 billion, a price-to-earnings ratio of 16.84, a PEG ratio of 1.18 and a beta of 0.79. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.73 and a current ratio of 0.73. UnitedHealth Group has a 52-week low of $208.07 and a 52-week high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.60 by $0.13. The business had revenue of $60.30 billion for the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.04 earnings per share.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.66%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 27.95%.

In related news, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the completion of the sale, the director now directly owns 64,726 shares of the company’s stock, valued at $16,400,921.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of the stock in a transaction that occurred on Tuesday, March 19th. The shares were sold at an average price of $257.32, for a total value of $1,286,600.00. Following the sale, the director now directly owns 182,454 shares of the company’s stock, valued at $46,949,063.28. The disclosure for this sale can be found here. Insiders have sold 17,930 shares of company stock valued at $4,587,133 over the last ninety days. 0.87% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its position in UnitedHealth Group by 3.1% in the fourth quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock worth $17,396,391,000 after buying an additional 2,123,417 shares during the last quarter. Vanguard Group Inc. increased its position in UnitedHealth Group by 1.6% in the third quarter. Vanguard Group Inc. now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after buying an additional 1,073,505 shares during the last quarter. Vanguard Group Inc increased its position in UnitedHealth Group by 1.6% in the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after buying an additional 1,073,505 shares during the last quarter. FMR LLC increased its position in UnitedHealth Group by 1.9% in the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock worth $16,063,258,000 after buying an additional 1,232,189 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund increased its position in UnitedHealth Group by 50,446.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock worth $214,000 after buying an additional 53,244,249 shares during the last quarter. 86.68% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: Golden Cross

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.